219 related articles for article (PubMed ID: 33279623)
1. Intratumoral CD45
Chen J; Qiao YD; Li X; Xu JL; Ye QJ; Jiang N; Zhang H; Wu XY
Cancer Lett; 2021 Feb; 499():85-98. PubMed ID: 33279623
[TBL] [Abstract][Full Text] [Related]
2. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
[TBL] [Abstract][Full Text] [Related]
3. Sex Matters: Physiological Abundance of Immuno-Regulatory CD71+ Erythroid Cells Impair Immunity in Females.
Mashhouri S; Koleva P; Huynh M; Okoye I; Shahbaz S; Elahi S
Front Immunol; 2021; 12():705197. PubMed ID: 34367164
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD71
Shim YA; Campbell T; Weliwitigoda A; Dosanjh M; Johnson P
Exp Hematol; 2020 Jun; 86():53-66.e1. PubMed ID: 32450207
[TBL] [Abstract][Full Text] [Related]
5. Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.
Zhu WH; Chen J; Huang RK; Zhang Y; Huang ZX; Pang XQ; Hu B; Yang Y; Li X
Theranostics; 2023; 13(13):4316-4332. PubMed ID: 37649603
[No Abstract] [Full Text] [Related]
6. CD71+ erythroid cells from neonates born to women with preterm labor regulate cytokine and cellular responses.
Miller D; Romero R; Unkel R; Xu Y; Vadillo-Ortega F; Hassan SS; Gomez-Lopez N
J Leukoc Biol; 2018 Apr; 103(4):761-775. PubMed ID: 29389020
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
8. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.
Duan Z; Gao J; Zhang L; Liang H; Huang X; Xu Q; Zhang Y; Shen T; Lu F
Oncotarget; 2015 Dec; 6(42):44239-53. PubMed ID: 26517519
[TBL] [Abstract][Full Text] [Related]
9. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
10. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
11. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.
Cai XY; Wang JX; Yi Y; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
Asian Pac J Cancer Prev; 2014; 15(2):775-80. PubMed ID: 24568494
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
[TBL] [Abstract][Full Text] [Related]
14. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.
Shahbaz S; Bozorgmehr N; Koleva P; Namdar A; Jovel J; Fava RA; Elahi S
PLoS Biol; 2018 Dec; 16(12):e2006649. PubMed ID: 30550561
[TBL] [Abstract][Full Text] [Related]
15. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
[TBL] [Abstract][Full Text] [Related]
16. CD71
Namdar A; Koleva P; Shahbaz S; Strom S; Gerdts V; Elahi S
Sci Rep; 2017 Aug; 7(1):7728. PubMed ID: 28798335
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Yao Q; Bao X; Xue R; Liu H; Liu H; Li J; Dong J; Duan Z; Ren M; Zhao J; Song Q; Yu H; Zhu Y; Lu J; Meng Q
Medicine (Baltimore); 2017 Apr; 96(17):e6735. PubMed ID: 28445292
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma.
Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P
J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135
[No Abstract] [Full Text] [Related]
[Next] [New Search]